Press Release
PharmaNest to Present Seven Digital Pathology and AI Communications and Abstracts at the International Liver Congress — EASL 2024, Including Analytical and Clinical Validation
PharmaNest, a leader in high-resolution, single-fiber quantitative Digital Pathology and Artificial Intelligence, showcases the performance of its FibroNest Ph-FCS digital biomarker for quantifying fibrosis severity and its clinical utility in Phase 2 and Phase 3 studies for patients with Metabolic Associated Steatohepatitis (MASH). Read More
Press Release
PowerPhone Expands Integration Capabilities With SmartCOP’s Computer Aided Dispatch System
PowerPhone announces their integration with SmartCOP's SmartCAD with Total Response 911 protocol software. This integration gives PSAPs using SmartCAD a seamless and unparalleled flow of information between the two systems, allowing for call takers to dispatch emergency responses quickly and efficiently. Read More
Press Release
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survival Versus KEYTRUDA in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection
At a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% and the risk of distant metastasis or death by 62% compared to KEYTRUDA alone in these patients The 2.5-year recurrence-free survival rate of mRNA-4157 (V940) in combination with KEYTRUDA was 74.8% as compared to 55.6% for KEYTRUDA alone, with the benefit observed across exploratory subgroups The companies have initiated Phase 3 studies in patients with high-risk melanoma and non-small cell lung cancer, in addition to Phase 2 studies in patients with renal cell carcinoma and urothelial carcinoma and a Phase 2/3 study for cutaneous squamous cell carcinoma Read More
Press Release
NYSE: LYV Lawsuit Update NOTICE: Investors who lost money with shares of Live Nation Entertainment, Inc. (NYSE: LYV) should contact the Shareholders Foundation
The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in NYSE: LYV shares. Investors in Live Nation Entertainment, Inc. (NYSE: LYV) shares should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554. Read More
Press Release
NASDAQ: XRAY Lawsuit Update Alert: Investors who lost money with shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) should contact the Shareholders Foundation
The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in NASDAQ: XRAY shares. Investors in NASDAQ: XRAY shares should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554. Read More
Press Release
Rekor Discover(TM) Takes Center Stage at NaTMEC 2024
Company Introduces Next-Generation Solution for AI-based Traffic Studies and Analytics Rekor Previews Advanced New Features to Help DOTs Meet Emerging Government Policies for Air Quality, Data Management, AI Innovation, and Cyber Security for Protecting Critical Transportation Infrastructure Read More
Press Release
MediTelecare Expands Behavioral Health Services to Urban Environments, Embracing In-Person Psychiatry and Psychology Offerings
MediTelecare is a pioneering behavioral health services provider committed to delivering compassionate care to individuals across a variety of settings. With a focus on innovation and accessibility, the company offers a blend of in-person and telehealth services, ensuring that everyone has access to the support they need, regardless of location. Read More
Press Release
Loop Industries Et Reed Management Signent Un Accord Pour Un Financement De 35 Millions D’euros Pour La Commercialisation Mondiale de la Technologie Infinite Loop(MC) Et Pour La Création D’une Coentreprise Française
LOOP ET REED MANAGEMENT SAS (« REED ») SIGNE UN ACCORD DE FINANCEMENT DE 35 MILLIONS D'EUROS POUR CONTRIBUER AU DÉPLOIEMENT COMMERCIAL MONDIAL DE LA TECHNOLOGIE INFINITE LOOPMC LOOP ET REED FORMERONT UNE COENTREPRISE POUR COMMERCIALISER LA TECHNOLOGIE DE LOOP EN EUROPE LE PARTENARIAT EST CONFORME À LA STRATÉGIE DE LOOP CONSISTANT À DÉPLOYER DES CAPITAUX DANS DES PAYS À FAIBLES COÛTS DE PRODUCTION, COMME L'INDE, ET À DISPOSER D'UN MODÈLE PLUS ALLÉGÉ EN ACTIFS, AXÉ SUR L'OCTROI DE LICENCES POUR SA TECHNOLOGIE DANS DES PAYS OÙ LES COÛTS SONT PLUS ÉLEVÉS Read More
Press Release